Journal
NATURE BIOTECHNOLOGY
Volume 39, Issue 1, Pages 9-12Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41587-020-00791-6
Keywords
-
Categories
Ask authors/readers for more resources
Antibody engineers are working to optimize SARS-CoV-2 antibodies in order to improve treatment outcomes, following mixed results in the clinic against COVID-19.
Following mixed results in the clinic against COVID-19, antibody engineers are further optimizing SARS-CoV-2 antibodies with the aim of improving outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
